Meta-analysis of the safety of different doses of teixepatide in the treatment of type 2 diabetes mellitus

doi:10.3969/j.issn.1672-3384.2023.10.007

ZHAO Yi-ru, ZHANG Lin, FANG Zhen-wei, SHI Xiu-jin, ZHANG Meng-di, LIN Yang

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (10) : 33-39.

PDF(1575 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (10) : 33-39. DOI: 10.3969/j.issn.1672-3384.2023.10.007

Original Article

Meta-analysis of the safety of different doses of teixepatide in the treatment of type 2 diabetes mellitus

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(10): 33-39 https://doi.org/10.3969/j.issn.1672-3384.2023.10.007

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1575 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-03-30	2023-10-30
Issue Date
2023-10-30

Please choose a citation manager

Content to export